Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Nexgenrx Inc. (NXG) Releases Q4 2025 Earnings: Revenue Up 46.5% as Net Loss Narrows

None

Nexgenrx Inc. (NXG) reported Q4 2025 results. Total revenue rose 46.5% year-over-year to $3.36 million, while gross profit increased 50.8% to $2.96 million. Cost of sales edged down 1.34% to $405.01k.

Operating profit grew 92.3% to $522.42k. The company recorded a net loss attributable to common shareholders of $116.42k, an improvement of 151.5% versus the prior year. Diluted earnings per share were $0.00, down 100.0% year-over-year.

Cash from operating activities surged 473.2% to $1.99 million, and cash and cash equivalents increased 192.8% to $3.48 million. Capital expenditures declined to $3.08k (down 82.8% YoY), while total liabilities rose to $21.11 million (up 32.6% YoY).

  • $3.36 million — Total revenue, +46.5% YoY
  • $2.96 million — Gross profit, +50.8% YoY
  • $522.42k — Operating profit, +92.3% YoY
  • $1.99 million — Cash from operations, +473.2% YoY
  • Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

    Nexgenrx INC. Insider Trading Activity

    NXG Insider Trades

    Nexgenrx INC. insiders have traded $NXG stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $NXG stock by insiders over the last 6 months:

    • TODD SUNDERLAND purchased 2,000 shares for an estimated $105,320
    • JOHN ALBAN purchased 1,000 shares for an estimated $50,380
    • JOHN M. MUSGRAVE (CEO & President) purchased 400 shares for an estimated $20,800
    • BLAKE NELSON (CFO & Treasurer) purchased 326 shares for an estimated $16,518
    • ANDREA MULLINS purchased 155 shares for an estimated $7,951

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    Nexgenrx INC. Hedge Fund Activity

    We have seen 19 institutional investors add shares of Nexgenrx INC. stock to their portfolio, and 19 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles